Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

23.34
Delayed Data
As of Jul 31
 +0.21 / +0.91%
Today’s Change
7.51
Today|||52-Week Range
25.25
+141.87%
Year-to-Date

Stock Price Forecast

The 8 analysts offering 12-month price forecasts for Halozyme Therapeutics Inc have a median target of 25.50, with a high estimate of 31.00 and a low estimate of 7.00. The median estimate represents a +9.25% increase from the last price of 23.34.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Halozyme Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.12
Sales
$21.8M
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 0.34%
 
 
 
 
 
 
Growthannually 14.20%
 
 
 
 
 
 

Sales

Growthquarterly 16.63%
 
 
 
 
 
 
Growthannually 23.66%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.